Metabolism of Antituberculosis Drugs in HIV-Infected Persons With Tuberculosis

Completed · Not applicable

Conditions studied: HIV Infections, Tuberculosis

In brief

The purpose of this study is to determine if a relationship exists between the level of antituberculosis drugs (isoniazid, rifampin, ethambutol, and pyrazinamide) in the blood and the outcome of HIV-positive patients with tuberculosis. This study also evaluates how these drugs are absorbed and metabolized in the body.

Key facts

Study ID
NCT00000950
Run by
National Institute of Allergy and Infectious Diseases (NIAID)
People needed
50
Last updated by the study team
2011-03-02

Who can join

Age: 13 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.